SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-08-057350
Filing Date
2008-03-14
Accepted
2008-03-14 15:52:35
Documents
9
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 970347
2 EMPLOYMENT AGREEMENT dex1018.htm EX-10.18 62975
3 AMENDMENT #1 TO FINANCIAL ADVISORY AND INVESTOR RETATIONS CONSULTING AGREEMENT dex1019.htm EX-10.19 54715
4 FIFTH AMENDMENT TO OFFICE LEASE dex1020.htm EX-10.20 23494
5 CONSENT OF DAVIDSON & COMPANY LLP dex231.htm EX-23.1 1769
6 CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 dex311.htm EX-31.1 5845
7 CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 dex312.htm EX-31.2 5839
8 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 dex321.htm EX-32.1 2701
9 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 dex322.htm EX-32.2 2679
  Complete submission text file 0001193125-08-057350.txt   1131804
Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33678 | Film No.: 08689465
SIC: 2834 Pharmaceutical Preparations